Ignite Creation Date:
2024-05-06 @ 8:32 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02767804
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-09
First Post:
2016-04-30
Brief Title:
eXalt3 Study Comparing X-396 Ensartinib to Crizotinib in ALK Positive Non-Small Cell Lung Cancer NSCLC Patients
Sponsor:
Xcovery Holdings Inc
Organization:
Xcovery Holdings Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-small Cell Lung Cancer |
Keywords:
| Name | View |
|---|---|
| ALK-positive NSCLC | View |